Profile data is unavailable for this security.
About the company
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
- Revenue in USD (TTM)228.88m
- Net income in USD10.13m
- Incorporated2018
- Employees232.00
- LocationLifeVantage Corp3300 TRIUMPH BLVD, SUITE 700LEHI 84043United StatesUSA
- Phone+1 (801) 432-9000
- Fax+1 (302) 636-5454
- Websitehttps://www.lifevantage.com/
More ▼
Mergers & acquisitions
| Acquired company | LFVN:NAQ since announced | Transaction value |
|---|---|---|
| Global Organics Merchants LLC | -62.88% | -- |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RADNOSTIX, INC. | 14.07m | -231.26k | 45.43m | 41.00 | -- | 11.09 | 269.90 | 3.23 | -0.0004 | -0.0004 | 0.0268 | 0.0078 | 0.8147 | 5.96 | 8.18 | 343,260.30 | -1.34 | 1.32 | -1.68 | 1.95 | 59.89 | 59.45 | -1.64 | 1.95 | 1.06 | -0.2928 | 0.5954 | 0.00 | 13.31 | 9.19 | 100.99 | -- | 28.22 | -- |
| Nasus Pharma Ltd | 0.00 | -1.19m | 49.04m | -- | -- | -- | -- | -- | -0.1319 | -0.1383 | 0.00 | -0.4762 | 0.00 | -- | -- | -- | -373.32 | -- | -- | -- | -- | -- | -- | -- | -- | -2.51 | -- | -- | -- | -- | -54.23 | -- | -- | -- |
| Janel Corp | 207.44m | 5.03m | 52.26m | 353.00 | 10.55 | 2.03 | 6.07 | 0.2519 | 4.18 | 4.18 | 172.09 | 21.75 | 1.47 | 32.80 | 4.14 | 587,657.30 | 4.02 | 1.76 | 13.35 | 5.33 | 31.33 | 26.69 | 2.73 | 0.9608 | 0.7013 | 3.10 | 0.3913 | 0.00 | 13.24 | 20.27 | 2,155.61 | -- | -14.58 | -- |
| Odonate Inc | 0.00 | -102.07m | 52.65m | 137.00 | -- | 2,022.38 | -- | -- | -108.70 | -108.70 | 0.00 | 74.17 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
| ImmuCell Corp | 27.77m | 2.32m | 56.45m | 70.00 | 24.11 | 1.89 | 11.24 | 2.03 | 0.2588 | 0.2588 | 3.09 | 3.29 | 0.6159 | 1.90 | 11.42 | 402,453.60 | 5.15 | -5.35 | 5.69 | -5.77 | 40.93 | 36.02 | 8.37 | -11.87 | 1.76 | 6.47 | 0.2415 | -- | 51.64 | 14.06 | 62.65 | -- | -19.66 | -- |
| Cumberland Pharmaceuticals, Inc. | 41.28m | -3.33m | 58.48m | 91.00 | -- | 2.24 | 46.34 | 1.42 | -0.2331 | -0.2331 | 2.79 | 1.75 | 0.5788 | 1.72 | 3.80 | 453,608.30 | -4.68 | -6.88 | -7.60 | -9.65 | 84.49 | 80.74 | -8.09 | -15.89 | 1.11 | -28.41 | 0.1688 | -- | -4.26 | 1.95 | -3.19 | -- | -29.32 | -- |
| Rafael Holdings Inc | 1.03m | -31.33m | 63.15m | 21.00 | -- | 0.7503 | -- | 61.37 | -0.8471 | -0.8471 | 0.0284 | 1.63 | 0.0107 | -- | 3.35 | 49,000.00 | -32.33 | -45.03 | -37.62 | -51.75 | 89.70 | -- | -3,034.89 | -8,772.74 | 3.98 | -- | 0.0074 | -- | 43.96 | -28.51 | 11.30 | -- | -47.65 | -- |
| LifeVantage Corp | 228.88m | 10.13m | 64.35m | 232.00 | 6.52 | 1.93 | 4.91 | 0.2812 | 0.7717 | 0.7717 | 17.47 | 2.61 | 3.72 | 2.41 | 84.88 | 986,538.80 | 16.47 | 9.17 | 24.68 | 14.08 | 80.29 | 80.73 | 4.43 | 2.93 | 1.30 | 495.71 | 0.00 | 35.06 | 14.17 | -0.3794 | 233.84 | -3.22 | -12.55 | -- |
| Pliant Therapeutics Inc | 0.00 | -175.50m | 70.05m | 171.00 | -- | 0.3497 | -- | -- | -2.87 | -2.87 | 0.00 | 3.26 | 0.00 | -- | -- | 0.00 | -48.60 | -38.70 | -52.81 | -41.26 | -- | -- | -- | -1,044.87 | -- | -- | 0.1319 | -- | -100.00 | -- | -30.35 | -- | 31.90 | -- |
| Pelthos Therapeutics Inc | 7.41m | -23.58m | 70.96m | 4.00 | -- | 1.22 | -- | 9.58 | -17.09 | -17.09 | 6.02 | 18.85 | 0.1152 | -- | -- | 1,851,500.00 | -36.68 | -- | -47.05 | -- | 68.73 | -- | -318.41 | -- | 1.04 | -12.32 | 0.00 | -- | -- | -- | -7.78 | -- | -- | -- |
| Scilex Holding Co | 40.36m | -375.84m | 72.09m | 30.00 | -- | -- | -- | 1.79 | -33.18 | -33.18 | 4.08 | -28.88 | 0.2145 | 7.27 | 1.85 | 350,956.50 | -177.73 | -- | -- | -- | 68.59 | 75.06 | -828.56 | -176.54 | 0.0429 | -3.76 | -- | -- | 21.07 | 21.89 | 56.40 | -- | -49.14 | -- |
| MindWalk Holdings Corp | 14.93m | -22.65m | 73.31m | 102.00 | -- | 5.60 | -- | 4.91 | -0.6294 | -0.6112 | 0.35 | 0.2804 | 0.4745 | 6.67 | 4.50 | -- | -72.01 | -32.32 | -90.53 | -36.45 | 58.50 | 55.79 | -151.78 | -100.97 | 4.09 | -23.68 | 0.17 | -- | 0.0082 | 11.77 | -11.25 | -- | 10.37 | -- |
| Polypid Ltd | 0.00 | -34.22m | 75.19m | 57.00 | -- | 4.89 | -- | -- | -2.98 | -2.98 | 0.00 | 0.9237 | 0.00 | -- | -- | 0.00 | -147.37 | -90.05 | -241.51 | -109.86 | -- | -- | -- | -- | -- | -22.38 | 0.1359 | -- | -- | -- | -21.61 | -- | -38.71 | -- |
| Assertio Holdings Inc | 137.35m | -28.92m | 81.75m | 58.00 | -- | 0.7727 | 37.04 | 0.5952 | -4.71 | -4.71 | 20.93 | 16.49 | 0.4611 | 1.35 | 1.47 | 2,368,138.00 | -9.71 | -15.74 | -17.07 | -24.19 | 68.16 | 82.29 | -21.06 | -42.01 | 1.43 | -- | 0.2702 | -- | -17.83 | -11.45 | 93.50 | -- | -- | -- |
Data as of Feb 06 2026. Currency figures normalised to LifeVantage Corp's reporting currency: US Dollar USD
46.25%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Capital Management Corp.as of 30 Sep 2025 | 2.06m | 16.25% |
| Renaissance Technologies LLCas of 30 Sep 2025 | 852.02k | 6.71% |
| Sudbury Capital Management LLCas of 06 Nov 2025 | 749.33k | 5.90% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 679.12k | 5.35% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 492.39k | 3.88% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 271.41k | 2.14% |
| Geode Capital Management LLCas of 30 Sep 2025 | 243.58k | 1.92% |
| Millennium Management LLCas of 30 Sep 2025 | 242.69k | 1.91% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 167.66k | 1.32% |
| Envestnet Asset Management, Inc.as of 30 Sep 2025 | 111.76k | 0.88% |
More ▼
Data from 30 Sep 2025 - 12 Jan 2026Source: FactSet Research Systems Inc.
